A customer reported 2 (b)(6) results with the determine hiv 1/2 ag/ab combo 25t.This report represents patient two (2) of two (2).The customer reported the results as p-24 antigen (ag) positive.Sample information was not provided.Confirmatory testing results (not specified) were (b)(6).No further patient information was provided.There was no death based on the determine hiv 1/2 ag/ab combo results.The alere hiv 1/2 ag-ab product insert indicates reactive test results should be confirmed by additional testing using other tests.Specimens from individuals with toxoplasma igg, human anti-mouse antibodies, rheumatoid factor, elevated triglycerides (above 600 mg/dl), herpes simplex virus infection, hospitalized, and cancer patients may give (b)(6) test results.When the source patient is ag and/or ab (b)(6), and receives unnecessary short-term art treatment, the risk of short- and medium-term toxicity with the current recommended art prophylaxis regimen is primarily transient metabolic abnormalities, which appear to be primarily mild and reversible after treatment is interrupted.As the sex and/or pregnancy status of the patient is unknown, given that the risk of short and medium-term toxicity to a possible fetus is unknown, this case shall be reported.
|